Purple Biotech News

Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 15 20:08

Purple Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(8.69%),Steven Boyd(8.69%)

Nov 15 06:27

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 4 20:54

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 25 19:22

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 10 19:44

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 9 19:46

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Oct 3 04:06

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 18 18:38

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 12 04:20

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 20 04:03

Purple Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 16 20:18

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 9 04:14

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Aug 6 04:02

Purple Biotech | 424B3: Prospectus

Aug 1 01:02

Purple Biotech | EFFECT: Others

Jul 31 18:05

Purple Biotech | CORRESP: CORRESP

Jul 27 01:04

Purple Biotech | UPLOAD: Others

Jul 27 01:04

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jul 25 19:38

Purple Biotech | F-1: Registration statement for securities of certain foreign private issuers

Jul 23 05:03

Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jul 19 20:56